We are live on ! Find out more
EAM

Eventide Asset Management Portfolio holdings

AUM $6.05B
1-Year Est. Return 76.64%
This Fund
S&P 500
This Quarter Est. Return
+16.69%
1 Year Est. Return
+76.64%
3 Year Est. Return
+247.17%
5 Year Est. Return
+285.6%
10 Year Est. Return
+2,546.71%
AUM
$1.64B
AUM Growth
+$3.83M
Cap. Flow
-$183M
Cap. Flow %
-11.16%
Top 10 Hldgs %
30.28%
Holding
138
New
10
Increased
27
Reduced
20
Closed
13

Top Buys

Rank Stock Value
1
AYI icon
Acuity Brands
AYI
+$21.3M
2
ROL icon
Rollins
ROL
+$14M
3
SNA icon
Snap-on
SNA
+$13.9M
4
DOOR
MASONITE INTERNATIONAL CORP
DOOR
+$13.6M
5
WSO icon
Watsco Inc
WSO
+$12.9M

Top Sells

Rank Stock Value
1
FSLR icon
First Solar
FSLR
+$27.4M
2
CELG
Celgene Corp
CELG
+$24.6M
3
CCI icon
Crown Castle
CCI
+$21.2M
4
SYNA icon
Synaptics
SYNA
+$21M
5
CBI
Chicago Bridge & Iron Nv
CBI
+$16.9M

Sector Composition

Rank Sector Weight
1 Healthcare 35.44%
2 Technology 16.99%
3 Consumer Discretionary 14.48%
4 Industrials 10.84%
5 Utilities 4.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DBVT
51
DBV Technologies
DBVT
$817M
$9.07M 0.55%
24,960
– –
ONCE
52
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
$9.01M 0.55%
150,000
– –
AYR
53
DELISTED
Aircastle Ltd
AYR
$8.51M 0.52%
428,600
– –
GWPH
54
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$8.43M 0.51%
63,500
-10,000
-14% -$956K
XNCR icon
55
Xencor
XNCR
$1.59B
$8.43M 0.51%
344,000
– –
KITE
56
DELISTED
Kite Pharma, Inc.
KITE
$8.3M 0.51%
148,600
– –
TSLA icon
57
Tesla
TSLA
$1.22T
$8.16M 0.5%
600,000
– –
BPMC
58
DELISTED
Blueprint Medicines
BPMC
$7.87M 0.48%
265,000
– –
SAGE
59
DELISTED
Sage Therapeutics
SAGE
$7.83M 0.48%
170,000
– –
TSRO
60
DELISTED
TESARO, Inc.
TSRO
$7.52M 0.46%
75,000
-15,000
-17% -$1.4M
PRTA icon
61
Prothena Corp
PRTA
$440M
$7.2M 0.44%
120,000
– –
CSLT
62
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
$7.11M 0.43%
1,708,600
– –
BMRN icon
63
BioMarin Pharmaceuticals
BMRN
$11.7B
$6.94M 0.42%
75,000
– –
EPIX
64
DELISTED
ESSA Pharma
EPIX
$6.83M 0.42%
135,971
– –
CERN
65
DELISTED
Cerner Corp
CERN
$6.68M 0.41%
108,200
– –
EXR icon
66
Extra Space Storage
EXR
$31.3B
$6.35M 0.39%
80,000
-90,000
-53% -$7.6M
NBIX icon
67
Neurocrine Biosciences
NBIX
$18.7B
$6.33M 0.39%
125,000
– –
CPN
68
DELISTED
Calpine Corporation
CPN
$6.32M 0.39%
500,000
-1,030,000
-67% -$13.9M
RARE icon
69
Ultragenyx Pharmaceutical
RARE
$2.56B
$6.2M 0.38%
87,400
– –
ALNY icon
70
Alnylam Pharmaceuticals
ALNY
$27.4B
$6.1M 0.37%
90,000
– –
NVAX icon
71
Novavax
NVAX
$1.22B
$4.53M 0.28%
108,985
– –
CEMP
72
DELISTED
Cempra, Inc.
CEMP
$4.47M 0.27%
184,900
– –
TGTX icon
73
TG Therapeutics
TGTX
$8.19B
$4.16M 0.25%
537,600
– –
BOLD
74
DELISTED
Audentes Therapeutics, Inc
BOLD
$4.01M 0.24%
+225,000
New +$3.41M
CHRS icon
75
Coherus Oncology
CHRS
$227M
$3.88M 0.24%
145,000
– –
1 2
3
4 5

Similar funds

HPG
Harvest Portfolios Group Oakville, Ontario, Canada $6.06B AUM 16.63% 1-Year Est. Return
EMPI
Elo Mutual Pension Insurance Espoo, Finland $6.06B AUM 24.33% 1-Year Est. Return
RCG
Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return
JWBC
John W. Bristol & Co New York $6.08B AUM 16.51% 1-Year Est. Return
AAM
Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
CM
CastleKnight Management New York $6B AUM 121.87% 1-Year Est. Return
CIS
Capital International Sarl Los Angeles, California $6.11B AUM 32.29% 1-Year Est. Return

Eventide Asset Management's Q3 2016 Portfolio in Review

As of Q3 2016, Eventide Asset Management held 138 positions worth $1.64B, up 0.23% from $1.63B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Eventide Asset Management withdrew a net $183M in Q3 2016, closing 13 positions and reducing 20 holdings. Its most notable exit was First Solar, an estimated $27.4M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 35% of assets, up from 31% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Eventide Asset Management opened a new position in Acuity Brands worth $21.2M.

  • Eventide Asset Management's largest Q3 2016 buy was Acuity Brands: 80,000 shares worth $21.2M.
  • Eventide Asset Management added most to 8point3 Energy Partners LP in Q3 2016, an estimated $5.01M increase.
  • Eventide Asset Management's biggest Q3 2016 reduction was Celgene Corp, cutting an estimated $24.6M.
  • Eventide Asset Management fully exited First Solar in Q3 2016, selling an estimated $27.4M.
  • Eventide Asset Management's ten largest holdings make up 30% of its $1.64B portfolio in Q3 2016.
  • Eventide Asset Management opened 10 new positions and closed 13 in Q3 2016.
  • Eventide Asset Management's portfolio value rose 0.23% quarter-over-quarter to $1.64B.

Based on Eventide Asset Management's 13F filing for Q3 2016, filed 14 Nov 2016.